Gender-specific incidence of autoimmune diseases from national registers

Journal of Autoimmunity

Volumn 69, Issue , 2016, Pages 102-106

  Ji, Jianguang ^a   Sundquist, Jan ^a,b   Sundquist, Kristina ^a,b  

^a LUND UNIVERSITY   (Sweden)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Autoimmune diseases; Gender; Incidence; National databases

Indexed keywords

ADDISON DISEASE; AGE DISTRIBUTION; AMYOTROPHIC LATERAL SCLEROSIS; ANKYLOSING SPONDYLITIS; ARTICLE; AUTOIMMUNE DISEASE; AUTOIMMUNE HEMOLYTIC ANEMIA; BEHCET DISEASE; CHOREA MINOR; CROHN DISEASE; DERMATOMYOSITIS; DISCOID LUPUS ERYTHEMATOSUS; FEMALE; GENDER; HASHIMOTO DISEASE; HUMAN; HYPERTHYROIDISM; IDIOPATHIC THROMBOCYTOPENIC PURPURA; INCIDENCE; INTERNATIONAL CLASSIFICATION OF DISEASES; LOCALIZED SCLERODERMA; LUPOID HEPATITIS; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; MYASTHENIA GRAVIS; ONSET AGE; PERNICIOUS ANEMIA; POLYARTERITIS NODOSA; POLYMYOSITIS; PRIMARY BILIARY CIRRHOSIS; PRIORITY JOURNAL; PSORIASIS; REITER SYNDROME; RHEUMATIC FEVER; RHEUMATIC HEART DISEASE; RHEUMATIC POLYMYALGIA; RHEUMATOID ARTHRITIS; SARCOIDOSIS; SEX DIFFERENCE; SJOEGREN SYNDROME; SYSTEMIC LUPUS ERYTHEMATOSUS; SYSTEMIC SCLEROSIS; ULCERATIVE COLITIS; WEGENER GRANULOMATOSIS; AUTOIMMUNE DISEASES; HEALTH SURVEY; REGISTER; SWEDEN;

AGE OF ONSET; AUTOIMMUNE DISEASES; FEMALE; HUMANS; INCIDENCE; MALE; POPULATION SURVEILLANCE; REGISTRIES; SEX FACTORS; SWEDEN;

EID: 84961195626     PISSN: 08968411     EISSN: 10959157     Source Type: Journal    
DOI: 10.1016/j.jaut.2016.03.003     Document Type: Article

References (33)

1. Beeson P.B. Age and sex associations of 40 autoimmune diseases. Am. J. Med. 1994, 96:457-462.
2. Moroni L., Bianchi I., Lleo A. Geoepidemiology, gender and autoimmune disease. Autoimmun. Rev. 2012, 11:A386-A392.
3. Shoenfeld Y., Tincani A., Gershwin M.E. Sex gender and autoimmunity. J. Autoimmun. 2012, 38:J71-J73.
4. Hohenester S., Oude-Elferink R.P., Beuers U. Primary biliary cirrhosis. Semin. Immunopathol. 2009, 31:283-307.
5. Eriksson S., Lindgren S. The prevalence and clinical spectrum of primary biliary cirrhosis in a defined population. Scand. J. Gastroenterol. 1984, 19:971-976.
6. Myszor M., James O.F. The epidemiology of primary biliary cirrhosis in north-east England: an increasingly common disease?. Q. J. Med. 1990, 75:377-385.
7. Myers R.P., Shaheen A.A., Fong A., Burak K.W., Wan A., Swain M.G., Hilsden R.J., Sutherland L., Quan H. Epidemiology and natural history of primary biliary cirrhosis in a Canadian health region: a population-based study. Hepatology 2009, 50:1884-1892.
8. Turchany J.M., Uibo R., Kivik T., Van de Water J., Prindiville T., Coppel R.L., Gershwin M.E. A study of antimitochondrial antibodies in a random population in Estonia. Am. J. Gastroenterol. 1997, 92:124-126.
9. Shibata M., Onozuka Y., Morizane T., Koizumi H., Kawaguchi N., Miyakawa H., Kako M., Mitamura K. Prevalence of antimitochondrial antibody in Japanese corporate workers in Kanagawa prefecture. J. Gastroenterol. 2004, 39:255-259.
10. Lleo A., Battezzati P.M., Selmi C., Gershwin M.E., Podda M. Is autoimmunity a matter of sex?. Autoimmun. Rev. 2008, 7:626-630.
11. Miner W. Status of multiple sclerosis. Ann. N. Y. Acad. Sci. 1954, 58. 541-720ed.
12. Confavreux C., Aimard G., Devic M. Course and prognosis of multiple sclerosis assessed by the computerized data processing of 349 patients. Brain A J. Neurol. 1980, 103:281-300.
13. Ramagopalan S.V., Goldacre R., Skingsley A., Conlon C., Goldacre M.J. Associations between selected immune-mediated diseases and tuberculosis: record-linkage studies. BMC Med. 2013, 11:97.
14. Hemminki K., Sundquist K., Sundquist J., Ji J. Risk of cancer of unknown primary after hospitalization for autoimmune diseases. Int. J. Cancer J. Int. du Cancer 2015, 137:2885-2895.
15. Sundquist J., Sundquist K., Ji J. Autism and attention-deficit/hyperactivity disorder among individuals with a family history of alcohol use disorders. eLife 2014, 3:e02917.
16. Ludvigsson J.F., Andersson E., Ekbom A., Feychting M., Kim J.L., Reuterwall C., Heurgren M., Olausson P.O. External review and validation of the Swedish national inpatient register. BMC Public Health 2011, 11:450.
17. G. Ionescu. vol. 2016. http://icd10cmcode.com/icd9to10conversion.php.
18. Heap G.A., van Heel D.A. The genetics of chronic inflammatory diseases. Hum. Mol. Genet. 2009, 18:R101-R106.
19. Shu X., Ji J., Li X., Sundquist J., Sundquist K., Hemminki K. Cancer risk among patients hospitalized for Type 1 diabetes mellitus: a population-based cohort study in Sweden. Diabetes Med. A J. Br. Diabetes Assoc. 2010, 27:791-797.
20. Ji J., Hemminki K., Sundquist J., Sundquist K. Ethnic differences in incidence of type 1 diabetes among second-generation immigrants and adoptees from abroad. J. Clin. Endocrinol. Metab. 2010, 95:847-850.
21. Jarvholm B., Burdorf A. Emerging evidence that the ban on asbestos use is reducing the occurrence of pleural mesothelioma in Sweden. Scand. J. Public Health 2015, 43:875-881.
22. Esteve J., Benhamou E., Raymond L. Statistical Methods in Cancer Research 1994, vol. 128. IARC, Lyon.
23. Cooper G.S., Stroehla B.C. The epidemiology of autoimmune diseases. Autoimmun. Rev. 2003, 2:119-125.
24. Jacobson D.L., Gange S.J., Rose N.R., Graham N.M. Epidemiology and estimated population burden of selected autoimmune diseases in the United States. Clin. Immunol. Immunopathol. 1997, 84:223-243.
25. Rasch S., Phillip V., Schmid R.M., Algul H. Epidemiology, clinical presentation, diagnosis and treatment of autoimmune pancreatitis: a retrospective analysis of 53 patients. Pancreatol. Off. J. Int. Assoc. Pancreatol. 2016, 16(1):73-77.
26. Castiblanco J., Sarmiento-Monroy J.C., Mantilla R.D., Rojas-Villarraga A., Anaya J.M. Familial aggregation and segregation analysis in families presenting autoimmunity, polyautoimmunity, and multiple autoimmune syndrome. J. Immunol. Res. 2015, 2015:572353.
27. Selmi C., Mix E., Zettl U.K. A clear look at the neuroimmunology of multiple sclerosis and beyond. Autoimmun. Rev. 2012, 11:159-162.
28. Selmi C., Brunetta E., Raimondo M.G., Meroni P.L. The X chromosome and the sex ratio of autoimmunity. Autoimmun. Rev. 2012, 11:A531-A537.
29. Meda F., Folci M., Baccarelli A., Selmi C. The epigenetics of autoimmunity. Cell. Mol. Immunol. 2011, 8:226-236.
30. Shoenfeld Y., Selmi C., Zimlichman E., Gershwin M.E. The autoimmunologist: geoepidemiology, a new center of gravity, and prime time for autoimmunity. J. Autoimmun. 2008, 31:325-330.
31. Selmi C. The X in sex: how autoimmune diseases revolve around sex chromosomes. Best Pract. Res. Clin. Rheumatol. 2008, 22:913-922.
32. Arber S., McKinlay J., Adams A., Marceau L., Link C., O'Donnell A. Patient characteristics and inequalities in doctors' diagnostic and management strategies relating to CHD: a video-simulation experiment. Soc. Sci. Med. (1982) 2006, 62:103-115.
33. Vanderpump M.P. The epidemiology of thyroid disease. Br. Med. Bull. 2011, 99:39-51.